Cargando…

Treatment with a DPP-4 inhibitor at time of hospital admission for COVID-19 is not associated with improved clinical outcomes: data from the COVID-PREDICT cohort study in The Netherlands

PURPOSE: Inhibition of dipeptidyl peptidase (DPP-)4 could reduce coronavirus disease 2019 (COVID-19) severity by reducing inflammation and enhancing tissue repair beyond glucose lowering. We aimed to assess this in a prospective cohort study. METHODS: We studied in 565 patients with type 2 diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meijer, Rick I., Hoekstra, Trynke, van den Oever, Niels C. Gritters, Simsek, Suat, van den Bergh, Joop P., Douma, Renée A., Reidinga, Auke C., Moeniralam, Hazra S., Dormans, Tom, Smits, Mark M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233181/ https://www.ncbi.nlm.nih.gov/pubmed/34222054 http://dx.doi.org/10.1007/s40200-021-00833-z

Ejemplares similares

What is the aetiology of dysnatraemia in COVID-19 and how is this related to outcomes in patients admitted during earlier and later COVID-19 waves? A multicentre, retrospective observational study in 11 Dutch hospitals
por: de Haan, Lianne, et al.
Publicado: (2023)

Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study
por: Collard, Didier, et al.
Publicado: (2021)

Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study
por: Chatterjee, Avishek, et al.
Publicado: (2021)

Outcomes of persons with coronavirus disease 2019 in hospitals with and without standard treatment with (hydroxy)chloroquine
por: Peters, Edgar JG., et al.
Publicado: (2021)

Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study
por: van Haaps, Thijs F., et al.
Publicado: (2021)

Overweight and Obesity Are Associated With Acute Kidney Injury and Acute Respiratory Distress Syndrome, but Not With Increased Mortality in Hospitalized COVID-19 Patients: A Retrospective Cohort Study
por: van Son, Jamie, et al.
Publicado: (2021)

Predicting mortality of individual patients with COVID-19: a multicentre Dutch cohort
por: Ottenhoff, Maarten C, et al.
Publicado: (2021)

Osteoporosis care during the COVID-19 pandemic in the Netherlands: A national survey
por: Peeters, Joséphine Jeanne Maria, et al.
Publicado: (2021)

Migration background and COVID-19 related intensive care unit admission and mortality in the Netherlands: A cohort study
por: Ocak, Gurbey, et al.
Publicado: (2023)

Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus
por: van den Oever, Inge A. M., et al.
Publicado: (2010)

Current and Future Incidence and Costs of Osteoporosis-Related Fractures in The Netherlands: Combining Claims Data with BMD Measurements
por: Lötters, Freek J. B., et al.
Publicado: (2016)

Procalcitonin-Guided Antibiotic Prescription in Patients With COVID-19: A Multicenter Observational Cohort Study
por: Hessels, Lisa, et al.
Publicado: (2023)

Trends in hospital and intensive care admissions in the Netherlands attributable to the very elderly in an ageing population
por: Haas, Lenneke E. M., et al.
Publicado: (2015)

Developing a Smoking Cessation Intervention for People With Severe Mental Illness Treated by Flexible Assertive Community Treatment Teams in the Netherlands: A Delphi Study
por: Küçükaksu, Müge H., et al.
Publicado: (2022)

Founder mutations in the Netherlands: familial idiopathic ventricular fibrillation and DPP6
por: Postema, P. G., et al.
Publicado: (2011)

The cost‐effectiveness of dapagliflozin compared to DPP‐4 inhibitors in the treatment of type 2 diabetes mellitus in the Netherlands
por: Van der Linden, N., et al.
Publicado: (2020)

SARS-CoV-2 seroprevalence in healthcare workers of a teaching hospital in a highly endemic region in the Netherlands after the first wave: a cross-sectional study
por: Bouwman, Maud, et al.
Publicado: (2021)

Quick adaptation of the organisation of general practices during the COVID-19 pandemic in the Netherlands
por: Groenewegen, Peter P., et al.
Publicado: (2023)

Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042–2050
por: Tonneijck, Lennart, et al.
Publicado: (2019)

Adherence to COVID-19 policy measures: Behavioral insights from The Netherlands and Belgium
por: van den Broek-Altenburg, Eline, et al.
Publicado: (2021)

Estimating monthly labour force figures during the COVID‐19 pandemic in the Netherlands
por: van den Brakel, Jan, et al.
Publicado: (2022)

The experiences and needs of re-entering nurses during the COVID-19 pandemic: A qualitative study
por: Noorland, Sofie A., et al.
Publicado: (2021)

Magnesium intake and colorectal cancer risk in the Netherlands Cohort Study
por: van den Brandt, P A, et al.
Publicado: (2007)

Substantial Impact of COVID-19 on Self-Reported Mental Health of Healthcare Professionals in the Netherlands
por: de Vroege, Lars, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on human salmonellosis in the Netherlands
por: Mughini-Gras, Lapo, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on kidney cancer care in the Netherlands
por: Yildirim, H., et al.
Publicado: (2022)

Incidence, prognostic factors, and outcomes of venous thromboembolism in critically ill patients: data from two prospective cohort studies
por: Eck, Ruben J., et al.
Publicado: (2021)

Unequal excess mortality during the Spanish Flu pandemic in the Netherlands
por: Rijpma, Auke, et al.
Publicado: (2022)

Ferritin Trajectories over Repeated Whole Blood Donations: Results from the FIND+ Study
por: Moazzen, Sara, et al.
Publicado: (2022)

Low SARS-CoV-2 Cq values in healthcare workers with symptomatic COVID-19 infections, regardless of symptom severity, The Netherlands, January to August 2022
por: van Rossum, Carsten, et al.
Publicado: (2023)

Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022
por: de Gier, Brechje, et al.
Publicado: (2023)

Gender differences in bodyweight change following COVID-19 lockdown measures in the Netherlands: a prospective longitudinal study
por: van den Broek, Thijs, et al.
Publicado: (2022)

A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19: a natural experiment due to drug shortages()
por: Swets, Maaike C., et al.
Publicado: (2023)

Measuring perceived benefit and disease-related burden in young cancer survivors: validation of the Benefit and Burden Scale for Children (BBSC) in the Netherlands
por: Maurice-Stam, Heleen, et al.
Publicado: (2011)

Policy and practice of programmatic management of latent tuberculosis infection in The Netherlands
por: de Vries, Gerard, et al.
Publicado: (2017)

Offline and Online Sexual Risk Behavior among Youth in the Netherlands: Findings from “Sex under the Age of 25”
por: De Graaf, Hanneke, et al.
Publicado: (2018)

Experimental studies to improve the reliability and validity of regulatory judgments on health care in the Netherlands: a randomized controlled trial and before and after case study
por: Tuijn, Saskia M, et al.
Publicado: (2014)

Impact of the COVID-19 pandemic on surgical care in the Netherlands
por: de Graaff, Michelle R, et al.
Publicado: (2022)

Mortality Monitoring in the Netherlands
por: van Asten, Liselotte, et al.
Publicado: (2014)

Overweight and obesity are not associated with worse clinical outcomes in COVID-19 patients treated with fixed-dose 6 mg dexamethasone
por: Wittermans, Esther, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_itn1i37sjmvi4qiv1g9gum518t